Assay | Inhibition at 10 μM | Assay | Inhibition at 10 μM |
---|---|---|---|
% | % | ||
A1 (h) | NK3 (h) | 21 | |
A2A (h) | 10 | Y1 (h) | |
A3 (h) | 13 | Y2 (h) | |
α1 (Nonselective) | NT1 (h) | ||
α2 (Nonselective) | Δ2 (h) | ||
β1 (h) | κ | 19 | |
AT1 (h) | μ (h) | ||
BZD (central) | ORL1 (h) | ||
B2 (h) | 5-HT1A (h) | ||
CCKA (h) (CCK1) | 11 | 5-HT1B | 14 |
D1 (h) | 5-HT2A (h) | 12 | |
D2S (h) | 5-HT3 (h) | ||
ETA (h) | 19 | 5-HT4a (h) | |
GABA (nonselective) | 5-HT6 (h) | ||
GAL2 (h) | 5-HT7 (h) | ||
IL-8B (h) (CXCR2) | sst (nonselective) | ||
CCR1 (h) | VIP1 (h) (VPAC1) | ||
H1 (central) | V1a (h) | ||
H2 | 15 | Ca2+ channel (L, verapamil site) | 13 |
MC4 (h) | 21 | K + V channel | |
ML1 | 12 | SK + Ca channel | |
M1 (h) | 20 | Na+ channel (site 2) | 23 |
M2 (h) | Cl– channel | ||
M3 (h) | NE transporter (h) | ||
NK2 (h) |
| DA transporter | 28 |
5-HT, serotonin; DA, dopamine